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Brown adipose tissue (BAT) possesses the inherent
ability to dissipate metabolic energy as heat through
uncoupled mitochondrial respiration. An essential
component of the mitochondrial electron transport
chain is coenzyme Q (CoQ). While cells synthesize
CoQ mostly endogenously, exogenous supplemen-
tation with CoQ has been successful as a therapy
for patients with CoQ deficiency. However, which tis-
sues depend on exogenous CoQ uptake as well as
the mechanism by which CoQ is taken up by cells
and the role of this process in BAT function are not
well understood. Here, we report that the scavenger
receptor CD36 drives the uptake of CoQ by BAT and
is required for normal BAT function. BAT from mice
lacking CD36 displays CoQ deficiency, impaired
CoQ uptake, hypertrophy, altered lipid metabolism,
mitochondrial dysfunction, and defective nonshiver-
ing thermogenesis. Together, these data reveal an
important new role for the systemic transport of
CoQ to BAT and its function in thermogenesis.
INTRODUCTION
Classical brown adipose tissue (BAT) is a unique type of adipose
tissue that is composed of adipocytes with multilocular lipid
droplets and a large amount of mitochondria, making it a highly
metabolically active organ that is responsible for nonshivering
thermogenesis both in neonate and adult humans (Aherne and
Hull, 1966; Cypess et al., 2009; Heaton, 1972; van Marken Lich-
tenbelt et al., 2009; Virtanen et al., 2009). The unabated growth of
the obesity epidemic and associated metabolic diseases such
as type 2 diabetes reflects our current lack of efficient strategies
for intervention and treatment of metabolic diseases (Zimmet
et al., 2001). Because BAT possesses the inherent ability to dissi-
pate metabolic energy as heat through uncoupled mitochondrialCrespiration, expanding BAT or enhancing its respiratory activity
could be a strategy for therapeutic intervention.
In order to generate a high metabolic rate for heat production,
brown adipocytes contain a large amount of mitochondria de-
nsely packed with cristae (Sell et al., 2004). These cells possess
an unparalleled ability to generate heat due to the dissociation
of electron transport chain respiration from ATP production
through uncoupling protein 1 (UCP1) (Argyropoulos and Harper,
2002). Located in the inner mitochondrial membrane, UCP1 pro-
vides an alternative route of entry for protons, allowing them to
bypass ATP synthase and in turn dissipate energy to generate
heat (Argyropoulos and Harper, 2002). Brown adipocyte mito-
chondria also display an elevated capacity for substrate utiliza-
tion, relying predominantly on the b oxidation of long-chain fatty
acids (LCFAs) (Sell et al., 2004). LCFAs can be taken up from the
circulation via fatty-acid transport proteins (FATPs) or can be
generated from endocytosed lipoproteins through a process
mediated in part by the scavenger receptor (SR) CD36 (Anderson
and Stahl, 2013; Coburn et al., 2001; Kuniyasu et al., 2002; Zeng
et al., 2003).
The SR family of transmembrane glycoproteins mediates the
binding and uptake of a broad range of ligands in a variety of tis-
sues (Greaves and Gordon, 2009). The SR family is comprised of
several classes, SR-A through SR-H (Plu¨ddemann et al., 2007).
SR class B receptors are unique from other classes of SRs in
that they have two transmembrane domains, an extracellular
ligand binding loop, and two short intracellular tails (Plu¨ddemann
et al., 2007). A defining member of the SR class B receptors is
CD36, an 88 kDa SR with multiple binding pockets and hydro-
phobic segments (Su and Abumrad, 2009). CD36 has been
shown to be required in a variety of tissues for the uptake of
several hydrophobic molecules, including LCFA and the carot-
enoid lycopene (Harmon and Abumrad, 1993; Moussa et al.,
2011). Originally identified as fatty acid translocase (FAT),
CD36 is also an established receptor for compounds of different
chemical nature, such as oxidized lipoproteins, thrombospon-
din, and collagen (Nergiz-Unal et al., 2011). CD36 is structurally
most similar to SR-BI, which has been shown to mediate the se-
lective uptake of cholesteryl esters from high-density lipoproteinell Reports 10, 505–515, February 3, 2015 ª2015 The Authors 505
(HDL) (Acton et al., 1996; Calvo et al., 1995; Calvo et al., 1998).
More recently, it was demonstrated that CD36 is required for
the endocytosis of lipoproteins by both macrophages and BAT
(Bartelt et al., 2011; Febbraio et al., 2000).
The lipid coenzyme Q (CoQ; also known as ubiquinone) is an
essential component of the mitochondrial electron transport
chain, functioning as a transporter of electrons from several
electron carriers (including complex I, complex II, glycerol-3-
phosphate [G3P] dehydrogenase [GPDH], and the electron
transferring flavoprotein of fatty acid b oxidation) to complex
III as well as an antioxidant (Crane, 2001). CoQ consists of a
quinone ring and an isoprenoid side chain of varying length
that is derived from the same mevalonate pathway as choles-
terol (Bentinger et al., 2010). The longer the isoprenoid side
chain, the more hydrophobic the CoQ molecule is (Bentinger
et al., 2010). Mice have predominantly CoQ with 9 isoprenoid
units (CoQ9), whereas humans have mostly CoQ10 (Sohet and
Delzenne, 2012). A large portion of CoQ is found in the inner
mitochondrial membrane, but a smaller portion can also be
found in the membranes of other organelles and the cytosol,
suggesting that it may have other functions in addition to trans-
porting electrons in the mitochondria (Bhagavan and Chopra,
2006).
Low CoQ levels are associated with cardiomyopathies, ag-
ing, and statin-induced myopathies (Bentinger et al., 2010).
There are also several genetic mutations directly affecting pro-
teins involved in the synthesis of CoQ, resulting in primary CoQ
deficiencies (Quinzii et al., 2008). Therefore, increasing CoQ
levels could be therapeutically beneficial for a variety of meta-
bolic diseases. Many tissues endogenously synthesize CoQ,
and the contribution of dietary CoQ is thought to be compara-
tively small (Bhagavan and Chopra, 2006). However, exoge-
nous uptake of CoQ from the circulation can be significant
in situations where CoQ levels are already low, such as in ge-
netic deficiencies, myopathies, and aging (Artuch et al., 2009).
Exactly how tissues take up CoQ and which tissues primarily
depend on exogenous CoQ have not been well studied (Pa-
dilla-Lo´pez et al., 2009), posing a considerable challenge to
the therapeutic use of CoQ in metabolic diseases, aging, and
mitochondrial function.
We speculated that, given the ability of CD36 and related re-
ceptors to mediate the uptake of hydrophobic molecules in a va-
riety of tissues, CD36 may be required in BAT for the uptake of
similar molecules, such as CoQ. Here we report that CD36 is
required for CoQ uptake in BAT and the maintenance of normal
CoQ levels, and thus nonshivering thermogenesis and BAT func-
tion. The ability of CD36 deficient BAT (Cd36/) to take up CoQ
was greatly impaired, and analysis of mitochondrial CoQ levels
showed that loss of CD36 caused a BAT-specific decrease in
CoQ9 and CoQ10. While BAT fatty acid uptake rates were un-
changed, the ability of Cd36/ BAT to take up another lipid,
CoQ, was greatly impaired. This CD36-dependent CoQ defi-
ciency impaired processes linked to classical CoQ function,
such as oxidative damage and reduced respiration. Together,
these data demonstrate a unique role for exogenous CoQ pro-
vided by CD36 in BAT mitochondrial function and reveal an un-
expected dependence of BAT homeostasis on the cellular levels
of CoQ.506 Cell Reports 10, 505–515, February 3, 2015 ª2015 The AuthorsRESULTS
CD36 Drives CoQ Uptake by BAT
CD36 has been shown to enhance uptake of LCFAs in the heart,
skeletal muscle, and white adipose tissue (WAT) (Abumrad et al.,
1993; Coburn et al., 2000; Van Nieuwenhoven et al., 1995). Be-
sides LCFAs, CD36 and related receptors have been shown to
play a role in the cellular uptake of a variety of other hydrophobic
molecules, including the selective uptake of cholesterol esters
from HDL by SR-B1 (Acton et al., 1996) and carotenoids such
as lycopenes by CD36 (Moussa et al., 2011). Since both lyco-
penes and CoQ are isoprenoids, we wanted to determine
whether CD36 can enhance cellular uptake of CoQ, particularly
in the context of a mitochondrial-rich tissue. CoQ was adminis-
tered to cells and animals via Intralipid, which is an emulsion
of soy bean oil, phospholipids, and glycerin (Taskinen et al.,
1983). We compared the uptake of solvent- and detergent-solu-
bilizedCoQ to Intralipid and found that receptor-mediated uptake
was only observed with Intralipid (data not shown). When we
treated HEK293 cells overexpressing CD36 with CoQ, the
CD36-expressing cells took up 57% more CoQ9 than control
cells (Figure 1A). Conversely, mature brown adipocytes from
Cd36/ BAT took up 42% less CoQ10 than WT cells, as quanti-
fied by high-performance liquid chromatography (HPLC) (Figures
1B and S1A). It is important to note that CoQ10 was used as a
substrate for uptake, as endogenous levels are low inmurine cells
anddiffered only slightly betweenWTandCd36/mature brown
adipocytes (Figure 1B). However, total CoQ levels, which are
dominated by CoQ9, were significantly suppressed in Cd36
/
mature brown adipocytes (WT 1.55 ± 0.18 pmol total CoQ/mg
protein versus Cd36/ 0.96 ± 0.11 pmol total CoQ/mg protein,
*p = 0.015). Taken together, these results suggest a role for
CD36 in CoQ uptake, particularly by BAT.
To determine whether CD36 enhances CoQ uptake in vivo,
we administered a CoQ-containing Intralipid mix to WT and
Cd36/ mice by intraperitoneal injection and then measured
CoQ levels by HPLC. At 24-hours postinjection, Cd36/ BAT
had taken up significantly less CoQ10 than WT mice (WT 0.159
± 0.034 pmol CoQ10/mg protein versus Cd36
/ 0.018 ± 0.006
pmol CoQ10/mg protein) (Figure 1Ci). Conversely, uptake of
exogenous CoQ10 was unaffected in the liver, which took up sig-
nificant amounts of injected CoQ10, and skeletal muscle, which
did not take up appreciable amounts of exogenous CoQ10 (Fig-
ures 1Cii and 1Ciii). Interestingly, while there was no difference
in serum CoQ10 levels between WT and Cd36
/ mice at base-
line, Cd36/ mice had significantly more CoQ10 in their serum
following injection of CoQ10 (WT 0.009 ± 0.002 pmol CoQ10/ml
serum versus Cd36/ 0.026 ± 0.005 pmol CoQ10/ml serum)
(Figure 1Civ).
To determine whether CoQ levels are perturbed in other
tissues from Cd36/ mice at baseline, we measured CoQ9
and CoQ10 in BAT, liver, heart, soleus, gastrocnemius, quadri-
ceps, adrenal gland, brain, and serum. While CoQ10 is the pre-
dominant species in humans, the mouse CoQ pool is composed
of approximately 90% CoQ9 and 10% CoQ10 (Lass et al., 1997).
Interestingly, both CoQ9 and CoQ10 levels in Cd36
/ BAT were
significantly decreased by approximately 40%–50% (Figure 1D).
This finding was confirmed by mass spectrometry, which
Figure 1. CD36 Is Required for CoQ
Transport
(A) HEK293 cells stably expressing CD36 or parent
vector (control) were treated with CoQ9 for 24 hr
(n = 5–6 per group). CoQ levels were measured by
HPLC and normalized to micrograms of protein.
(B) Primary mature brown adipocytes were iso-
lated from WT and Cd36/ BAT and treated with
either vehicle or CoQ10 for 3 hr (n = 5).
(C) (i–iv) WT and Cd36/ mice were injected
intraperitoneally with either vehicle (Intralipid) or
CoQ10. After 24 hr, tissues were isolated, and
CoQ10 levels were measured by HPLC and
normalized to micrograms of protein or microliters
of serum (n = 8–9).
(D) BAT, liver, heart, soleus, gastrocnemius,
quadriceps, adrenal gland, brain, and serum CoQ9
and CoQ10 levels inCd36
/ relative toWT (100%)
were measured by HPLC and normalized to
micrograms of protein (n = 3–6). A complete
table with the absolute CoQ values is included in
Table S1.
(E) CoQ10 levels were measured in lipoprotein
fractions from human serum by HPLC and
normalized to milliliters of fraction (n = 6).
*p < 0.05; **p < 0.005; ***p < 0.0005. Error bars
represent SEM. See also Figure S1 and Table S1.showed significantly decreased levels of both CoQ9 and CoQ10
in Cd36/ BAT (64% and 80% of WT, respectively) (Figures
S1B and S1C). In contrast, CoQ levels in the heart, skeletal mus-
cle, adrenal glands, brain, and serum from Cd36/ mice were
normal, while levels in the liver were slightly increased (Figure 1D;
Table S1).
These loss-of-function and gain-of-function studies in vitro
and in vivo suggest that CD36 facilitates direct cellular uptake
of CoQ in BAT. Given that CD36 can facilitate uptake of lipopro-
tein particles in BAT (Bartelt et al., 2011), we wanted to see in
which lipoprotein fraction CoQ is present. CoQ is most abundant
in the low-density lipoprotein (LDL) fraction (Figure 1E), but
absent from the nonlipoprotein fraction (data not shown), sug-
gesting that it may be transported through the circulation and
presented to the cell as a lipoprotein particle component (Tom-
asetti et al., 1999).Cell Reports 10, 505–515Alterations of Lipid Metabolism in
Cd36/ BAT
CD36 is most abundant in adipose tissue,
heart, lung, andmuscle, with less expres-
sion in spleen and liver (Figures 2A, S2A,
and S2B). In addition, there is no effect of
browning in WAT by CL-316,243 on the
expression of Cd36 in subcutaneous
and visceral WAT depots (Figure S2C).
To elucidate the role of CD36 in BAT, we
took advantage of mice lacking CD36
(Cd36/) (Febbraio et al., 1999). The
absence of CD36 in the BAT of these
mice was confirmed byWestern blot (Fig-
ures 2A and S2A). To identify specifically
where CD36 is expressed in BAT, weperformed an immunolocalization study for CD36 and UCP1.
Interestingly, CD36 was found to be located exclusively on the
plasma membrane in BAT, supporting a role for CD36 in the up-
take of hydrophobic molecules from the circulation (Figure 2B).
Given that CD36 is robustly expressed in BAT and thatCd36/
mice have decreased CoQ levels in BAT, we wanted to deter-
mine whether mice lacking CD36 had normal BAT morphology
and function. An appreciable difference in the morphology of
Cd36/ BAT compared with WT BAT was immediately noticed
by direct observation (Figure 2C). BAT lacking CD36 was signifi-
cantly larger and paler in color compared with BAT fromWTmice
at room temperature (Figure 2C). Following cold exposure, the
characteristic browning of BAT was absent in Cd36/ mice,
while the weight difference remained (Figure 2C). 3D recon-
struction of confocal microscopy scans of BAT sections stained
for neutral lipids with BODIPY confirmed that the marked, February 3, 2015 ª2015 The Authors 507
Figure 2. Pathologic TAG Storage in Cd36/ BAT
(A) Western blot for CD36 and b tubulin was performed on lysates fromWT andCd36/BAT, WAT, heart, lung, quadriceps muscle, spleen, and liver (n = 5). Data
are presented in arbitrary units as a ratio of CD36 normalized to tubulin.
(B) Colocalization of CD36 (green), UCP1 (red), and DAPI (blue) in a WT BAT cryosection. Scale bar represents 10 mm.
(C) Images of BAT from WT and Cd36/ mice and their weights before and after cold exposure (n = 3–6).
(D) Representative images of 3D reconstructions from cold-exposed mouse BAT sections stained with the fluorescently labeled TAG probe BODIPY 493/503
(green) and DAPI (blue).
(E) Genome-wide expression analysis was performed on RNA from WT and Cd36/ BAT (n = 3 per group). A summary table of misregulated genes identified
using a p% 0.05 threshold is presented. A complete list of misregulated genes is included in Tables S2 and S3.
(F) Lipase activity (expressed as nmol of FFA released/hour/mg protein of tissue lysate) from WT and Cd36/ BAT chunks (n = 4).
(legend continued on next page)
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hypertrophy in Cd36/ BAT was mainly due to increased lipid
droplet accumulation (Figure 2D) and lipid droplet volume (me-
dian volume: 18.5 mm3 WT versus 205 mm3 Cd36/). These re-
sults show that BAT lacking CD36 displays whitening and
increased lipid droplet size.
To determine whether the accumulation of lipids in Cd36/
BAT was due to defective lipolysis, we first measured lipase ac-
tivity in mature brown adipocytes from WT and Cd36/ mice.
No significant difference in lipase activity was observed between
WT and Cd36/ BAT (Figure 2F). The lipolysis rate in WAT was
unchanged (Figure S3A), indicating that the release of fatty acids
from WAT into the circulation was unaffected in Cd36/ mice.
However, the lipolysis rate in both the basal state and after stim-
ulation by forskolin/IBMX was significantly reduced in Cd36/
BAT (Figure S3B).
We speculated that the defects observed in Cd36/ BAT
morphology could arise from alterations in lipid trafficking. We
found that LCFA uptake rates of isolated primary mature brown
adipocytes from Cd36/ mice were comparable to WT and re-
sponded normally to stimulation by the b3-adrenergic receptor
agonist CL-316,243 (WT 1.84- ± 0.51-fold change over untreated
versus Cd36/ 2.02- ± 0.53-fold change over untreated) (Fig-
ure 2G), while Lpl expression in Cd36/ BAT was elevated by
1.48-fold compared withWT BAT (*p = 0.007) (Table S3), arguing
against defective free fatty acid (FFA) uptake or production. To
determine whether there was a defect in circulating FFA, we
measured FFA levels in the serum of WT and Cd36/ mice.
Consistent with previous reports (Coburn et al., 2000; Febbraio
et al., 1999), circulating FFA levels were actually elevated
2-fold in Cd36/mice both before and after cold exposure (Fig-
ure 2H). Cholesterol levels were unchanged between WT and
Cd36/ mice in BAT, liver, quad, and serum (Figure 2I).
Impaired Mitochondrial Substrate Utilization in
Cd36/ BAT
To determine whether there are bioenergetic consequences as a
result of BAT CoQ deficiency, we assessed LCFA b oxidation in
intact mature brown adipocytes using [14C]-palmitic acid.
Despite normal fatty acid uptake potential (Figure 2G), production
of 14CO2 by Cd36
/ brown adipocytes was reduced by approx-
imately 50% compared with WT brown adipocytes, demon-
strating that substrate utilization is decreased in Cd36/ BAT
and suggesting a potential mitochondrial defect (Figure 3A).
A series of Clark electrode respiratory tests with isolated BAT
mitochondria using a variety of substrates was performed. In iso-
lated mitochondria, electrons from pyruvate and malate enter
complex I, while electrons from succinate and G3P bypass com-
plex I and are transferred directly to CoQ by complex II or GPDH,
respectively (Crane, 2001). The basal rates of respiration were
decreased in BAT mitochondria from Cd36/ mice (although
not statistically significant for succinate and pyruvate/malate)
(Figure 3B). Furthermore, the defect in respiration with G3P(G) Maximal BODIPY 510/512-labeled FFA uptake capacity of untreated and CL-3
(n = 3).
(H) WT and Cd36/ fasting plasma FFA levels at 0, 2.5, and 5 hr of cold exposu
(I) Cholesterol was extracted from BAT, liver, quadriceps, and serum and norma
*p < 0.05; **p < 0.005; ***p < 0.0005. Error bars, SEM. See also Figures S2 and S
Ccould be rescued with the addition of CoQ2, suggesting that
the cause of impaired respiration is due to the decreased levels
of CoQ (Figure 3B). Electron microscopy revealed significantly
smaller mitochondria in Cd36/ BAT compared with WT (Fig-
ure 3C). Mitochondria in Cd36/ BAT were 53% smaller in
area compared with WT (Figure 3D). Furthermore, the mitochon-
drial volume density in Cd36/ BAT was 51% that of WT (Fig-
ure 3E). Taken together, these results demonstrate impaired
mitochondrial function in Cd36/ BAT due to decreased CoQ
levels.
Genome-wide expression analysis in BAT from WT and
Cd36/ mice showed changes in the expression of several
functional families, including mitochondrial related genes, but
no misregulation of genes encoding electron transport chain
proteins (Figure 2E; Tables S2 and S3). To determine whether cy-
tochrome levels within the mitochondrial electron transport
chain were affected, we measured the content of cytochromes
c, c1, b, and a, but saw no differences in their levels in Cd36/
BAT mitochondria (Figure 3F).
LowCoQ levels are associated with increased reactive oxygen
species (ROS) production and oxidative damage (Murphy, 2009).
To determine whether Cd36/ BAT mitochondria are undergo-
ing oxidative stress, we measured H2O2 production. Cd36
/
BATmitochondria had a significantly higher rate of H2O2 produc-
tion (Figure 3G), indicating that there is more ROS production
and possibly oxidative damage in the mitochondria of Cd36/
BAT.
Cd36/ Mice Are Cold Intolerant in spite of
Increased Shivering
To determine whether the observed altered lipid metabolism and
decrease in CoQ levels affected BAT function, we exposed WT
and Cd36/ mice to 4C for 5 hours and then measured their
core body temperature. While there was no difference in body
temperature under normal conditions, we did detect a prominent
thermogenic defect in Cd36/ mice compared with WT mice
housed at 4C (Figure 4A). Since CD36 is also expressed in mus-
cle, we wanted to exclude a contribution of defects from shiv-
ering thermogenesis (Bastie et al., 2004; Van Nieuwenhoven
et al., 1995). Therefore, we assessed shivering thermogenesis
utilizing an innovative wireless accelerometer (Figure 4B) that
can be used to detect both animal movement as well as shivering
(Figure 4C). We found that neither overall activity (Figure 4D) nor
shivering amplitude (Figure 4F) was impaired, yet shivering dura-
tion was increased (Figure 4E). These results indicate that
Cd36/ mice display a defect in nonshivering thermogenesis
and a compensatory but insufficient upregulation of shivering
thermogenesis in response to cold exposure. This hypothesis
was further supported by the finding that, while restingmetabolic
rates were comparable between WT and Cd36/ mice, the
characteristic increase in VO2, VCO2, and heat production in
response to a single injection of the b3-adrenergic receptor16,243-treated primary mature brown adipocytes fromWT and Cd36/mice
re (n = 4).
lized to either milligrams of tissue or microliters of serum (n = 3).
3 and Tables S2 and S3.
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agonist CL-316,243 was absent in Cd36/ mice (Figure 4G).
This suggests that altered lipid metabolism and CoQ deficiency
in Cd36/ BAT has functional consequences.
DISCUSSION
The unique ability of mitochondria-rich BAT to generate heat and
regulate nonshivering thermogenesis, coupled with its recent
identification in adult humans, has driven research into the ther-
apeutic use of this tissue for metabolic diseases. The presence
of CD36 in BAT and its known role as a transporter of lipids in
other tissues prompted us to examine whether CD36 could func-
tion as a transporter of the highly hydrophobic mitochondrial
electron carrier CoQ in BAT. Here we show that CD36 drives
the uptake of CoQ by BAT and is required for normal BAT func-
tion. The findings presented in this study demonstrate a unique
relationship between CD36 and CoQ in brown fat and identify
CD36 and CoQ as new factors that may limit the metabolic activ-
ity of BAT.
Efficient import of CoQ specifically into BAT by CD36 is an
interesting finding. A number of studies have indicated the
importance of CD36 and other class B SRs in the uptake of hy-
drophobic isoprenoids, such as lycopene, lutein, and b carotene
(Borel et al., 2011, 2013; Harmon and Abumrad, 1993; Kiefer
et al., 2002;Moussa et al., 2011), whose transport in aqueous en-
vironments is reliant on specific protein carriers such as CD36
(Kuzuyama and Seto, 2012; Reboul and Borel, 2011). In addition,
genetic variants within CD36 are associated with varying blood
levels of carotenoids (Borel et al., 2011, 2013). Carotenoids are
synthesized from isoprenoids, which are highly hydrophobic pre-
cursors whose transport in aqueous environments is reliant on
specific protein carriers such as CD36 (Kuzuyama and Seto,
2012; Reboul and Borel, 2011). CoQ is another molecule with a
hydrophobic isoprenoid side chain whose cellular uptake may
be facilitated by transport proteins (Bentinger et al., 2010; Pa-
dilla-Lo´pez et al., 2009). Our finding that Cd36/ BAT had a
smaller CoQ pool than WT BAT suggested that CD36 may be
required for efficient CoQ uptake or catabolism by BAT.
Loss-of-function and gain-of-function studies in vitro and
in vivo demonstrate that, indeed, CD36 facilitates direct cellular
uptake of CoQ, and show a clear BAT-autonomous CoQ uptake
defect. While the precise mechanism of CoQ uptake by CD36 in
BAT remains unclear at this point, uptake of lipoprotein particles
by CD36, long believed to be restricted to liver and macro-
phages, was elegantly shown recently to also occur in BAT (Bar-
telt et al., 2011). In other tissues, CD36 has been shown to take
up cholesteryl esters from HDL, as well as oxidized LDL, throughFigure 3. Impaired Substrate Utilization and Mitochondrial Dysfunctio
(A) Production of 14CO2 from
14C-[Palmitic acid] in Cd36/ primary mature brow
(B)WT andCd36/BATmitochondrial respiration rates usingG3Pwith andwitho
(OCRs) were measured and presented as mg O2/min/50 mg protein (n = 6–9).
(C) Representative electron microscopy images from WT and Cd36/ BAT; 343
(D) Quantification of the mitochondrial area from WT and Cd36/ BAT EM imag
(E) Quantification of the mitochondrial volume density from WT and Cd36/ BA
(F) Cytochrome content was measured in isolated mitochondria from WT and Cd
(G) The rate of H2O2 production was measured in WT and Cd36
/ BAT mitocho
*p < 0.05; **p < 0.005; ***p < 0.0005. Error bars represent SEM.
Cendocytosis (Acton et al., 1996; Calvo et al., 1998). Furthermore,
CoQ is most abundant in the LDL fraction (Figure 1E), suggesting
that it may be transported through the circulation and presented
to the cell as a lipoprotein particle component (Tomasetti et al.,
1999). Therefore, it is possible that CD36 mediates the uptake
of lipoproteins containing CoQ through endocytosis. Alterna-
tively, CD36 alone or in conjunction with other proteins may
mediate the selective uptake of CoQ from bound lipoproteins.
It is important to note that CoQdeficiency and impaired uptake
were found only in BAT lacking CD36 and not in several other tis-
sues tested. In both WT and Cd36/ mice the liver, which has
very little CD36, was still able to take up CoQ, while the quadri-
ceps muscle, which has moderate levels of CD36, did not take
up exogenous CoQ (Figures 1Cii and 1Ciii). This pattern of tissue
CoQ uptake is very similar to the pattern of CD36-dependent li-
poprotein uptake by Cd36/ tissues that, like our CoQ uptake,
falls into three categories: CD36-dependent uptake (i.e., BAT),
CD36-independent uptake (i.e., liver), and low overall uptake,
as exemplified by skeletal muscle (Bartelt et al., 2011). These
findings demonstrate a tissue-specific role for CD36 not only in
lipoprotein uptake but also CoQ uptake.
Overall, BAT is a major sink for exogenous CoQ. In spite of its
size, BAT had the highest CoQ uptake rate of all the tissues
examined, removing five times as much circulating CoQ as the
16 times larger liver. Moreover, the quadriceps muscle takes up
250 times less CoQ than BAT. Remarkably, Cd36/ mice had
three times more CoQ10 in their serum compared with WT
mice, yet they had eight times lessCoQ10 in their BAT, suggesting
that CoQaccumulated in the circulation instead of being taken up
by BAT in Cd36/mice. These data suggest that, of the tissues
examined, BAT is amajor destination for circulating CoQ and that
CD36 plays a role in the clearance of CoQ from the serum.
While we cannot exclude a contribution of CoQ de novo syn-
thesis to the CD36-dependent CoQ deficiency, it is most likely
that CoQ synthesis is weakly, if at all, affected. Gene expression
analysis by microarray identified a multitude of genes involved in
pathways leading to CoQ synthesis that were upregulated rather
than downregulated in Cd36/ BAT (Tables S2 and S3). This
could be interpreted as a possible compensatory response to
the decrease in the pools of CoQ in Cd36/ BAT. For example,
HMG-CoA synthase, which catalyzes an early step in the meval-
onate synthesis pathway, was upregulated (Tables S2 and S3).
This pathway generates both cholesterol andCoQ, and reduction
of HMG-CoA synthase, a common precursor in the synthesis of
these two molecules, suggested deficiencies in the levels of me-
valonate or its derivatives cholesterol and CoQ (Bentinger et al.,
2010). However, the level of cholesterol was unchanged betweenn in Cd36/ BAT
n adipocytes relative to WT (100%) and normalized for mg of protein (n = 3).
ut CoQ2, succinate, and pyruvate/malate (Pyr/Mal). Oxygen consumption rates
,000 magnification. Scale bar represents 0.2 mm.
es (n = 4).
T EM images (n = 4).
36/ BAT and normalized to mg of mitochondrial protein (n = 3).
ndria and presented as pmol/min/mg protein (n = 4).
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Figure 4. Defective Nonshivering Thermogenesis in Cd36/ BAT
(A) Mouse core body temperature measured rectally before and after 5 hr of cold exposure (n = 6).
(B) The wireless accelerometer used in this study was built at UC Berkeley and is approximately the size of a coin (a U.S. quarter). Shivering and movement were
monitored by attaching the device shown to the mouse back.
(C) Accelerograph showing millisecond-resolution monitoring of movement and shivering in a WT mouse. The large bursts of acceleration indicate animal
movement. A zoomed-in accelerograph displays regular shivering spikes in a cold-exposed WT mouse.
(legend continued on next page)
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WT andCd36/BAT (Figure 2I), indicating that the early compo-
nents of theCoQsynthesis pathwaywere not affected inCd36/
BAT. The unchanged cholesterol levels could also hint at a facil-
itative rather than endocytic uptake mechanism, although further
studies are required to address the point. Furthermore, while all
tissues synthesize CoQ endogenously at varying rates (Thelin
et al., 1992), the biosynthesis of CoQ in BAT is very low, yet its
levels are quite high, suggesting that CoQ must be taken up
from the circulation (Sekhar et al., 1990). The low CoQ synthesis
rate in BAT coupled with our findings that cholesterol levels are
unaffected in Cd36/ BAT suggests that loss of CD36 most
likely does not affect CoQ synthesis.
Mice lacking CD36 also displayed defective nonshivering ther-
mogenesis. Unfortunately, we were unable to test whether exog-
enous CoQ would rescue the thermogenic defect in Cd36/
mice, as CoQ10 supplementation by a single intraperitoneal in-
jection failed to raise total CoQ levels in Cd36/ BAT to that
of baseline WT levels (Figure S4). This is most likely due to the
fact that CD36 is required for the uptake of sufficient CoQ by
BAT.
The data presented in this study identify a mechanism for
the regulation of BAT function and thermogenesis via CD36-
mediated CoQ uptake. We have shown a clear requirement for
CD36 in BAT function and CoQ homeostasis. Identifying the pre-
cise mechanism of CoQ uptake by CD36 will aid in the enhance-
ment of CoQ supplementation therapies for patients with CoQ
deficiencies as well as a way to stimulate brown fat activity for
the treatment of obesity and associated metabolic disorders.
EXPERIMENTAL PROCEDURES
Animal Experiments
All animal procedures were approved by the University of California Berkeley
Animal Care and Use Committee. Cd36/ mice on a C57BL/6J background
were kindly provided by Dr. Maria Febbraio (Febbraio et al., 1999). Control
C57BL/6J mice (referred to as WT in this paper) were purchased from
the Jackson Laboratory. All animal experiments were conducted in 8- to
20-week-old male mice housed under standard conditions. They were given
free access to water and rodent chow (Harlan Teklad #2018). For cold-expo-
sure studies, singly caged mice were housed at 4C for 5 hr. Core body tem-
perature was measured rectally using a lubricated thermistor probe (Yellow
Springs Instruments) at 30 min intervals. Shivering was determined by attach-
ing a wireless accelerometer (weight = 1.5 g) to the mouse back and quantified
with millisecond resolution in 3D for 2 hr. For serum analysis, retro-orbital
blood was collected from anesthetized mice prior to and following 2.5 and
5 hr cold exposure. Serum samples were analyzed for nonesterified fatty acids
and glucose using colorimetric kits according to the manufacturer’s protocol
(Wako Chemicals).
CoQ Uptake Assays
For cellular uptake of CoQ, cells were incubated with 10 mMCoQ9 or CoQ10. A
1 mM CoQ stock solution was generated by dissolving CoQ in 100% ethanol
and heating for 5 min to 65C. Ten ml of 1 mM CoQ was then added to 90 ml
Intralipid (Sigma #I141) and heated to 65C for 5 min. This solution was then
mixed with 1 ml prewarmed complete media and immediately added to cells.(D–F) Motor activity (D), time spent shivering (E), and shivering amplitude (F) of fa
(G) Oxygen consumption and carbon dioxide and heat production measurements
CL-316,243 (n = 3). Data are presented as fold change compared with before CL
*p < 0.05. Error bars represent SEM.
CCells were incubated at 37C with 10 mM CoQ for up to 6 hr, at which time
themedia were removed and cells were washed three times with PBS and har-
vested for CoQ extraction. For in vivo uptake of CoQ, mice were injected intra-
peritoneally with 200 ml of either a commercial CoQ10 solution (LiQSorb, Tish-
con) or a CoQ10/Intralipid solution. Tomake this solution, a 29mMCoQ10 stock
solution was generated by dissolving CoQ10 (Sigma #C9538) in 100% ethanol
and heating for 15 min to 65C. Twenty ml of 29 mM CoQ10 was then added to
180 ml Intralipid (Sigma #I141) and heated to 65C for 15min. Two hundred ml of
this 1.45 mM CoQ10/Intralipid were injected intraperitoneally per mouse.
Serum and tissues were collected 24 hr following injection for CoQ extraction.
CoQ Extraction and Measurement by HPLC
CoQ levels were determined as previously described (Podda et al., 1999). In
brief, whole tissue, isolated mitochondria, or cells were homogenized in 1 ml
PBS containing 0.5 mg/ml of the antioxidant butylated hydroxytoluene. One
ml of 0.1 M SDS was added to samples, followed by vortexing and sonication.
An aliquot (50 ml) was removed for determining protein concentration by bicin-
choninic acid (BCA) assay, and CoQ4 was then added as an internal standard.
Two ml of 100% ethanol were added, followed by vortexing and sonication.
Two ml of hexane were then added, and the samples were vortexed for 90 s
and centrifuged at 1,000 g for 3 min. The upper hexane layer was dried under
gentle nitrogen stream in a 37C water bath. The dried remnants were then re-
suspended in 160 ml of 100%ethanol and briefly heated at 65C.Quantification
by HPLC was determined using the Waters HPLC-UV detection system. One
hundred ml of the resuspension were injected and run on a C18-ODS Hypersil
reverse-phase column (Thermo Scientific #30105-254630). A gradient was
used consisting of solution A (80% methanol/20% water) and solution B
(100% ethanol) with a flow rate of 1 ml/min for 40 min: min 0–16, 39% A and
61% B; over min 16–18 change to 100% B; min 18–28 100% B; over min
28–30 change to 39% A and 61% B; min 30–40, 39% A and 61% B. CoQ9
peak appears around 24 min, and CoQ10 peak appears around 25 min. A stan-
dard curve was generated using commercial CoQ9 and CoQ10 (Sigma) to
determine absolute amounts.
Lipolysis and Lipase Activity
Lipase activity was performed as previously described (Ahmadian et al., 2009).
For lipolysis rates, 5 mg of BAT tissue chunks was incubated in serum-free
Dulbecco’s modified Eagle’s medium with and without 200 mM 3-isobutyl-1-
methylxanthine (IBMX) and 10 mM forskolin (Sigma). Lipolysis rate was deter-
mined at 15 min intervals as the amount of glycerol released using the free
glycerol reagent from Sigma (#F6428) according to the manufacturer’s
recommendations.
LCFA Uptake
Fatty acid uptake assays were performed as previously described (Wu et al.,
2006) using primary mature brown adipocytes at 37C in 13 Hank’s balanced
salt solution containing 0.1% fatty acid-free bovine serum albumin (BSA) and
BODIPY 500/510 C1, C12-labeled fatty acid (Invitrogen #D3823). The reaction
was stopped at 0.5, 1, and 5 min by the addition of ice-cold PBS containing
0.1% BSA and 500 mM Phloretin (Sigma). Single-cell fluorescence was deter-
mined at 510 nm by fluorescence-activated cell sorting using the FACScalibur
instrument (BD Biosciences).
Palmitic Acid Oxidation
Palmitic acid oxidation assays were performed as previously described (Ah-
madian et al., 2009). Primary mature brown adipocytes were incubated at
37C for 1 hr in sealed vials containing modified Krebs buffer plus 1% BSA,
5 mM glucose, and 5 mM [14C]-Palmitate (50 mCi/mmol, PerkinElmer). The re-
action was stopped with 5N H2SO4, and the
14CO2 produced was trapped in
filter papers soaked in 200 ml 2-phenethylamine (Sigma). The filter paperssted mice exposed to 4C for 2 hr (n = 5).
3 hr after intraperitoneal administration of the b3-adrenergic receptor agonist
injection.
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were transferred to scintillation vials containing 5 ml scintillation liquid (Eco-
scint XR, National Diagnostics) and the radioactivity was measured in a LS
6000 scintillation counter (Beckman Coulter).
Mitochondrial Isolation, Respiration, and Cytochrome Content
Mitochondria were purified as previously described (Parker et al., 2009). All
steps were carried out at 4C. Tissues were chopped with scissors in sodium
chloride-Tris-EDTA (STE) buffer (250 mM sucrose, 5 mM Tris, and 2 mM EGTA
[pH 7.4]) plus 1% BSA, homogenized manually (3 strokes with a loose-fit and
10 strokes with a tight-fit dounce homogenizer) and centrifuged at 8,500 g for
10 min. For BAT, the top fat layer was removed, and the tube walls were
cleaned of fat. The pellet was resuspended in STE with 1% BSA and centri-
fuged at 400 g for 10 min. The supernatant was placed in a new tube and
centrifuged at 8,500 g. The mitochondrial pellet was washed twice in BSA-
free STE and resuspended in BSA-free STE. Protein concentration was deter-
mined by the BCA method. Mitochondrial respiration rates were recorded in a
Clark-type electrode (Strathkelvin Instruments) as previously described (Oelk-
rug et al., 2010). Fifty mg of mitochondria were incubated at 37C under agita-
tion in a final volume of 100 ml in buffer containing 50 mM KCl, 10 mM TES,
1 mM KH2PO4, and 2 mM MgCl2, 1 mM EGTA, 0.46 mM CaCl2, 0.4% BSA,
and 1 mg/ml oligomycin (Sigma) (pH 7.4). Ten mM G3P, 5 mM pyruvate,
5 mM malate, or 4 mM succinate were used as substrates. Twenty mM
CoQ2 were used in rescue experiments. Cytochrome difference spectra
were determined by dithionite reduced minus air oxidized scans on a DW-2
Olis dual-beam spectrophotometer. Isolated mitochondria (0.5–1.0 mg/ml)
were incubated in sodium chloride-HEPES-EDTA medium. Concentrations
of cytochromes c, c1, b, and awere calculated by simultaneous equation solv-
ing according to previously published studies (Schneider et al., 1980; Williams,
1964). The wavelength pairs and extinction coefficients for each cytochrome
were cytochrome c 550–535 nm, 25.1 mM1 cm1; cytochrome c1 554–
540 nm, 24.1 mM1 cm1; cytochrome b 563–577 nm, 23.2 mM1 cm1; cy-
tochrome a 605–630 nm, 13.1 mM1 cm1.
Statistical Analysis
Differences between two groupswere determined using unpaired t test. Differ-
ences between three or more groups were analyzed by one-way ANOVA fol-
lowed by Tukey’s post hoc test for multiple comparisons. Power calculations
were performed using online software (http://statisticalsolutions.net) with a
desired sample size of ten on data sets with an n = 3. Data are presented as
the mean value, and error bars represent SEM. Asterisks indicate significant
comparisons, and specific p values are listed in each figure legend.
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